Seagen Requests Director Review Of Unpatentability Decision In Adcetris® Patent PGR - Patent

On February 14, 2024, Seagen requested director review of the PTAB's January 16th Final Written Decision ("FWD") in PGR2021-00030 finding antibody-drug conjugate claims in U.S. Patent No. 10,808,039...

Related Keywords

April Breyer Menon ,Seagen Adcetris , ,Final Written Decision ,Final Written Decision Finding ,Mondaq ,Seagen Requests Director Review Of Unpatentability Decision In Adcetris Xae Patent Pgr ,Intellectual Property ,Patent ,